Respipure Pharma Private Limited
About Respipure Pharma Private Limited
Data last updated:
Respipure Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Trihal Pharma Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 January 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC375528. Its GSTIN is 27AALCR5961R1ZB (Maharashtra).
The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Shekhar Shrawankumar Bhuwania and Manish Shah Mangilal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop – 75 Floor – 7th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.41 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹9 Cr and EBITDA of -₹3.63 Cr.
As per MCA filings, the company has open charges of ₹77.43 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop – 75 Floor – 7th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Respipure Pharma Private Limited
The main business activity of Respipure Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Respipure Pharma Private Limited FY 2025 filings available
Respipure Pharma Private Limited reported revenue of ₹45.41 Lakh (up 1202% YoY) for FY 2025.
Financial Statement Summary of Respipure Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.63 Cr | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹9 Cr | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Respipure Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Respipure Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Respipure Pharma Private Limited
Respipure Pharma Private Limited is audited by VANITA BHUVA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VANITA BHUVA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Respipure Pharma Private Limited
Respipure Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shekhar Shrawankumar Bhuwania Also directs: Oc Bioscience Private Limited, Trihal Pharma Private Limited, Growlease Fintech I LLP and 5 more | Director | 15 Jun 2022 | 4 Years 3 Months | Current |
| Manish Shah Mangilal Also directs: Indira Consultancy LLP, Oc Bioscience Private Limited, Oc Specialities Private Limited and 4 more | Director | 27 Jan 2022 | 4 Years 8 Months | Current |
| Nishant Vaish Also directs: Aryann Chemical Trading Private Limited | Director | 27 Jan 2022 | 4 Years 8 Months | Current |
Ownership and Shareholding of Respipure Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Respipure Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2025 | Hdfc Bank Limited | ₹15 Lakh | Open |
| 18 Oct 2023 | Hdfc Bank Limited | ₹38.64 Cr | Open |
| 19 Dec 2022 | Hdfc Bank Limited | ₹38.64 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Respipure Pharma Private Limited
Respipure Pharma Private Limited has a workforce of 0 employees as of Mar 25, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Respipure Pharma Private Limited
Respipure Pharma Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Shekhar Shrawankumar Bhuwania ceased to be Additional Director on 29 Sep 2023.
Credit Ratings, Litigation & Regulatory Alerts for Respipure Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Respipure Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Respipure Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Respipure Pharma Private Limited
Respipure Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCR5961R1ZB | Maharashtra | Active | 01 Mar 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Respipure Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Respipure Pharma Private Limited
Respipure Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 January 2022 (4+ years old) and is registered under CIN U24290MH2022PTC375528.
Respipure Pharma reported revenue of ₹45.41 Lakh for FY 2025 (up 1202% YoY).
Respipure Pharma has 3 current directors:
- Shekhar Shrawankumar Bhuwania - Director
- Manish Shah Mangilal - Director
- Nishant Vaish - Director
Respipure Pharma reported a net loss of ₹9 Cr and EBITDA of -₹3.63 Cr for FY 2025, as per its filed financial statements.
The GSTIN of Respipure Pharma is 27AALCR5961R1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Respipure Pharma is U24290MH2022PTC375528. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Respipure Pharma was incorporated on 27 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Shekhar Shrawankumar Bhuwania ceased to be Additional Director on 29 Sep 2023. Shekhar Shrawankumar Bhuwania was appointed as Director on 15 Jun 2022. Manish Shah Mangilal was appointed as Director on 27 Jan 2022. Respipure Pharma has 4 board changes on record in total.
The registered office of Respipure Pharma is at Shop – 75 Floor – 7th Plot – 215 Free Press House Free Press Journal Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
Respipure Pharma has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹1 Cr.